epirubicin has been researched along with Canine Diseases in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blackwood, L; Finotello, R; Mason, SL | 1 |
| Cuvertoret-Sanz, M; Marco, A; MartÃnez, J; MartÃnez-Sogues, L; Novellas, R; Pastor, J; Roura, X; Solano-Gallego, L; Vila, A | 1 |
| Baines, S; Elliott, J | 1 |
| Kang, MH; Lee, YR; Park, HM | 1 |
| Blackwood, L; Grant, IA; Killick, DR; Marrington, AM | 1 |
| Blackwood, L; Cripps, P; Elliott, JW; Grant, IA; Marrington, AM | 1 |
| Baldi, A; Citro, G; Fanciulli, M; Spugnini, EP | 1 |
| Gall, TT; Kim, SE; Liptak, JM; Monteith, GJ; Woods, JP | 1 |
| Argyle, DJ; Cave, TA; Hine, R; Howie, F; Thompson, H | 1 |
1 review(s) available for epirubicin and Canine Diseases
| Article | Year |
|---|---|
Preclinical models in electrochemotherapy: the role of veterinary patients.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Cat Diseases; Cats; Cisplatin; Dog Diseases; Dogs; Drug Evaluation, Preclinical; Electrochemotherapy; Epirubicin; Head and Neck Neoplasms; Melanoma; Mitoxantrone; Neoplasms; Quinazolines; Sarcoma; Thiophenes | 2012 |
8 other study(ies) available for epirubicin and Canine Diseases
| Article | Year |
|---|---|
Epirubicin in the treatment of canine histiocytic sarcoma: sequential, alternating and rescue chemotherapy.
Topics: Animals; Antineoplastic Agents; Dog Diseases; Dogs; Epirubicin; Female; Histiocytic Sarcoma; Lomustine; Male; Retrospective Studies; Salvage Therapy; Survival Analysis | 2018 |
Hypercalcemia of Malignancy in a Dog Diagnosed With Cholangiocellular Carcinoma.
Topics: Animals; Antibiotics, Antineoplastic; Bile Duct Neoplasms; Cholangiocarcinoma; Dog Diseases; Dogs; Epirubicin; Hypercalcemia; Male; Paraneoplastic Syndromes; Parathyroid Hormone-Related Protein; Prednisone | 2019 |
A Retrospective Study of Multi-agent Chemotherapy including either Cyclophosphamide or Lomustine as Initial Therapy for Canine High-grade T-cell Lymphoma (2011-2017).
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Dog Diseases; Dogs; Epirubicin; Female; Lomustine; Lymphoma, T-Cell; Male; Neutropenia; Prednisolone; Retrospective Studies; United Kingdom; Vincristine | 2019 |
Anthracycline-induced cardiomyopathy in a dog treated with epirubicin.
Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathy, Dilated; Dog Diseases; Dogs; Epirubicin; Heart Failure; Lymphoma; Male | 2015 |
Toxicity associated with epirubicin treatments in a large case series of dogs.
Topics: Animals; Antibiotics, Antineoplastic; Dog Diseases; Dogs; Epirubicin; Female; Fever; Gastrointestinal Diseases; Male; Neoplasms; Neutropenia; Retrospective Studies | 2012 |
Epirubicin as part of a multi-agent chemotherapy protocol for canine lymphoma.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Dog Diseases; Dogs; Epirubicin; Female; Lymphoma; Male; Retrospective Studies | 2013 |
Epirubicin in the adjuvant treatment of splenic hemangiosarcoma in dogs: 59 cases (1997-2004).
Topics: Animals; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Dog Diseases; Dogs; Epirubicin; Female; Hemangiosarcoma; Male; Prognosis; Retrospective Studies; Splenectomy; Splenic Neoplasms; Survival Analysis; Time Factors; Treatment Outcome | 2007 |
Uterine carcinoma in a 10-month-old golden retriever.
Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Dog Diseases; Dogs; Epirubicin; Female; Uterine Neoplasms | 2002 |